BioSpace News Archive

Business

ChemDiv, DZNE and Torrey Pines Investment Launch Inflammasome Discovery Program of Translational Collaboration on Neurodegeneration

The overall goal of the collaboration is to leverage DZNE’s advanced research capabilities with ChemDiv’s commercial expertise to efficiently design and validate new therapeutic candidates for treatment of Alzheimer’s and other neurodegenerative diseases.

January 4, 2018
·
3 min read
Zora Announces CERT - A Validated Test for Cardiovascular and Diabetes Risk Prediction

Zora announces the expansion of its Coronary Event Risk Test to include prediction of type II diabetes.

January 4, 2018
·
4 min read
Business

Crinetics Pharmaceuticals Appoints Marc Wilson as Chief Financial Officer

Mr. Wilson joins Crinetics from Cidara Therapeutics, where he was Vice President of Finance and Accounting and Chief Accounting Officer.

January 4, 2018
·
2 min read
Drug Development

Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty Acid Oxidation Disorder Patients

The company expects that a decision on a potential filing for approval based on Phase 2 data will be made in mid-2018.

January 4, 2018
·
7 min read
Drug Development

Asterias Biotherapeutics Reports Milestone Targets for 2018

These achievements, combined with the Company’s financial resources position Asterias to achieve the following milestones during 2018.

January 4, 2018
·
6 min read
Business

BioPorto: Changes in the Board of Directors - Jan. 4, 2018

Board member Niels Christian Nielsen will not be seeking re-election at BioPorto’s Annual General Meeting on April 13, 2018.

January 4, 2018
·
1 min read
Business

Peli BioThermal Hires Dominic Hyde as New VP of Credo on Demand

With more than 23 years engineering expertise and leadership experience, Hyde will manage the worldwide expansion of Peli BioThermal’s Credo on Demand rental program.

January 4, 2018
·
2 min read
FDA

Cerebrotech Visor Receives FDA Clearance

The clearance includes a broad indication for use as an aid in the assessment of fluid volume differences between the cerebral hemispheres in patients undergoing neurologic assessment.

January 4, 2018
·
3 min read
Business

Rexahn Pharmaceuticals Announces the Appointment of Douglas J. Swirsky as President and Chief Financial Officer

Mr. Swirsky was most recently President, CEO and a director of GenVec.

January 4, 2018
·
4 min read
Biotech Beach

CURE Pharmaceutical Launches New Brand Focused on Patient Needs in Medication Delivery

CURE’s proprietary CUREfilm technology platform optimizes drug delivery for better patient outcomes and experiences.

January 4, 2018
·
3 min read